Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 32 of 38
Research on the Environment and Children's Health: Retinoblastoma
NCT00582049
Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy
NCT00074100
Quality Of Life Outcomes Following Treatment for Esophageal Cancer
NCT00598117
Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
NCT00072319
Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
NCT00072332
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
NCT00072358
Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
NCT00586846
Use of Screening Colonoscopy Among Minority Women and Men
NCT00613873
Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
NCT00072345
Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
NCT00587431
Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy
NCT00070031
Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
NCT00582829
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
NCT00587067
Imaging Brain Tumors With FACBC and Methionine
NCT00597246
Breast MRI Spectroscopy
NCT00577915
Adherence to Intensive Surveillance for Hereditary Breast Cancer
NCT00582803
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
NCT00067015
Massage Therapy in Treating Patients With Cancer Pain
NCT00082290
A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma
NCT00131898
Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer
NCT00601692
3-D Reconstruction of CT Scan Images in the Evaluation of Non-Specific Pulmonary Nodules
NCT00613041
Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations
NCT00579007
Alanosine in Treating Patients With Cancer
NCT00062283
DNA Repair and Genetic Susceptibility to Lung Cancer
NCT00611598
Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
NCT00058422
Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
NCT00058370
Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans
NCT00577811
Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma
NCT00595725
Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma
NCT00582270
The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections
NCT00597090
Family Access to Care Study (FACS)
NCT00582218
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
NCT00142571
Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma
NCT00059904
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
NCT00055705
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
NCT00059930
Polyglutamate Camptothecin in Treating Patients With Advanced Cancer
NCT00059917
MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
NCT00059995
Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel
NCT00705835
Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer
NCT00059891
Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer
NCT00579462
Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
NCT00058435
Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery
NCT00140868
Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.
NCT00590031
Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging
NCT00594724
Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
NCT00052572
Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma
NCT00052390
Psychostimulants for Fatigue in Prostate Cancer
NCT00138138
Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study
NCT00595062
SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study
NCT00590564
Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT00058396
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.